USD 5.81
(-0.85%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | 183.48 Thousand | 423.64 Thousand | 230.89 Thousand | -3645.34 |
Net Income | 212.65 Thousand | 316.79 Thousand | 402.09 Thousand | 284.69 Thousand |
Depreciation & Amortization | 66.82 Thousand | 37.71 Thousand | 26.47 Thousand | 11.81 Thousand |
Deferred income taxes | 35.88 Thousand | -639.17 | -273.36 | -41.15 |
Stock-based compensation | - | - | - | - |
Change in working capital | -135.28 Thousand | 40.95 Thousand | -218.08 Thousand | -315.6 Thousand |
Other non-cash items | 255.6 Thousand | 78.65 Thousand | 354.25 Thousand | 265.53 Thousand |
Investing Cash Flow | -107.52 Thousand | -212.78 Thousand | -132.93 Thousand | -31.9 Thousand |
Investments in PPE | -107.52 Thousand | -213.75 Thousand | -134.21 Thousand | -32.95 Thousand |
Acquisitions | - | 973.91 | 1276.10 | 1050.24 |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | 6558.00 | 8230.00 | -6.00 |
Financing Cash Flow | -176.28 Thousand | 24.58 Thousand | -120.03 Thousand | 94.52 Thousand |
Debt repayment | -151.98 Thousand | -76.18 Thousand | -52.01 Thousand | -94.52 Thousand |
Dividends payments | - | -52.29 Thousand | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | -24.3 Thousand | -21.38 Thousand | -68.02 Thousand | - |
Other Financing Activities | -172.17 Thousand | 22.07 Thousand | -438.68 Thousand | 652.4 Thousand |
Accounts receivables | -121.69 Thousand | -3461.54 | -122.24 Thousand | -39.62 Thousand |
Accounts payables | 49.2 Thousand | 33.34 Thousand | -141.29 Thousand | -107.2 Thousand |
Inventory | -46.06 Thousand | -4290.05 | -17.09 Thousand | -79.57 Thousand |
Other working capital | -16.73 Thousand | 15.36 Thousand | 62.55 Thousand | -89.2 Thousand |
Cash at beginning of period | 257.96 Thousand | 48.17 Thousand | 67.4 Thousand | 9819.00 |
Cash at end of period | 148.92 Thousand | 257.96 Thousand | 48.17 Thousand | 67.4 Thousand |
Capital Expenditure | -107.52 Thousand | -213.75 Thousand | -134.21 Thousand | -32.95 Thousand |
Effect of forex changes on cash | -26.29 Thousand | -99.15 Thousand | 8623.00 | 23.93 Thousand |
Net cash flow / Change in cash | -109.03 Thousand | 209.79 Thousand | -19.22 Thousand | 57.58 Thousand |
Free Cash Flow | 75.96 Thousand | 209.88 Thousand | 96.68 Thousand | -36.59 Thousand |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -36.84 Thousand | 472.18 Thousand | 212.65 Thousand | 472.18 Thousand | 281.16 Thousand | 281.16 Thousand |
Depreciation & Amortization | 34.73 Thousand | 144.88 Thousand | 66.82 Thousand | 144.88 Thousand | 106.09 Thousand | 106.09 Thousand |
Deferred income taxes | -2888.97 | - | 35.88 Thousand | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -86.71 Thousand | -157.15 Thousand | -135.28 Thousand | -157.15 Thousand | -361.56 Thousand | -361.56 Thousand |
Other non-cash items | -190.70 | 222.88 Thousand | 255.6 Thousand | 222.88 Thousand | -58.51 Thousand | -58.51 Thousand |
Investing Cash Flow | -437.83 Thousand | -370.01 Thousand | -107.52 Thousand | -370.01 Thousand | -10.88 Thousand | -10.88 Thousand |
Investments in PPE | -86.61 Thousand | -370.01 Thousand | -107.52 Thousand | -370.01 Thousand | -10.88 Thousand | -10.88 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -343.41 Thousand | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -7792.30 | - | - | - | - | - |
Financing Cash Flow | 575.7 Thousand | -596.07 Thousand | -176.28 Thousand | -596.07 Thousand | -28.41 Thousand | -28.41 Thousand |
Debt repayment | -156.04 Thousand | - | -151.98 Thousand | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 456.37 Thousand | - | -24.3 Thousand | - | - | - |
Other Financing Activities | -36.71 Thousand | -596.07 Thousand | -172.17 Thousand | -596.07 Thousand | -28.41 Thousand | -28.41 Thousand |
Accounts receivables | -92.46 Thousand | -351.23 Thousand | -121.69 Thousand | -351.23 Thousand | -213.45 Thousand | -213.45 Thousand |
Accounts payables | 31.85 Thousand | - | 49.2 Thousand | - | - | - |
Inventory | 19.40 | 5372.00 | -46.06 Thousand | 5372.00 | -168.56 Thousand | -168.56 Thousand |
Other working capital | -26.13 Thousand | 188.7 Thousand | -16.73 Thousand | 188.7 Thousand | 20.45 Thousand | 20.45 Thousand |
Cash at beginning of period | 144.15 Thousand | - | 257.96 Thousand | - | - | - |
Cash at end of period | 190.11 Thousand | -266.98 Thousand | 148.92 Thousand | -266.98 Thousand | -101.56 Thousand | -101.56 Thousand |
Capital Expenditure | -86.61 Thousand | -370.01 Thousand | -107.52 Thousand | -370.01 Thousand | -10.88 Thousand | -10.88 Thousand |
Effect of forex changes on cash | - | 16.3 Thousand | -26.29 Thousand | 16.3 Thousand | -29.45 Thousand | -29.45 Thousand |
Net cash flow / Change in cash | 45.95 Thousand | -266.98 Thousand | -109.03 Thousand | -266.98 Thousand | -101.56 Thousand | -101.56 Thousand |
Free Cash Flow | -178.52 Thousand | 312.79 Thousand | 75.96 Thousand | 312.79 Thousand | -43.69 Thousand | -43.69 Thousand |
TAR
1432
PALASHSECU
FFARMS
CVE
TECO